×
Hero Background

Sepsis Diagnostics Companies

ID: MRFR/MED/1574-HCR
85 Pages
Rahul Gotadki
October 2025

Sepsis diagnostics companies specialize in developing advanced medical technologies to swiftly and accurately identify sepsis, a life-threatening condition resulting from the body's extreme response to infection. These innovative firms employ cutting-edge methods, such as molecular diagnostics, biomarker analysis, and artificial intelligence algorithms, to detect sepsis markers in blood samples. 

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Sepsis Diagnostics Market Research Report- Forecast to 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Sepsis Diagnostics Market

Sepsis Diagnostics Key Companies


Latest Sepsis Diagnostics Companies Update



December 2023: Legend Biotech receives China National Medical Products Administration (NMPA) approval for LCAR-017 for relapsed/refractory B-cell lymphomas. This signifies the first regulatory approval for CAR T-cell therapy in China.November 2023: BioMarker has raised $30 million in a Series B funding round, demonstrating investor confidence in the company's AI-powered platform for analyzing brain scans and improving diagnosis of neurological disorders. Jan 2024: BlueRock Therapeutics releases encouraging Phase I/II data for autologous T-cell therapy for PD-L1 negative non-small cell lung cancer. this marks progress in tackling challenging cancer types with autologous therapies.October 2023: CTI BioTech's blood test for early sepsis detection, SepsiSTAT, wins FDA Breakthrough Device Designation. This could expedite the approval process and bring the test to market faster.Jan 2024: Magenta Therapeutics secures $165 million in Series D funding, aiming to advance product development and manufacturing capabilities.August 2023: Novartis expands CAR-T program partnership with Cellares, demonstrating continued commitment to CAR T-cell therapy development.

 

List of Sepsis Diagnostics Key Companies in the Market




  • Sandstone Diagnostics Inc. (US)




  • T2 Biosystems




  • Immunexpress (US)




  • Axis-Shield Diagnostics Ltd. (Scotland)




  • Becton Dickinson and Company (US)




  • EKF Diagnostics (UK)




  • Cube Dx GmbH (Austria)




  • Wolters Kulwer N.V. (Netherlands)




  • Amara Health (US)